Acticoat

05/01/2005 - "This study evaluated the cytotoxicity of Acticoat with CSS and the efficacy of Acticoat for the management of microbial contamination in CSS grafted to full-thickness wounds in athymic mice. "
08/01/2014 - "This study has demonstrated that both Acticoat(®) and Inadine(®) dressings can reduce the bacteria burden in a heavily contaminated soft tissue wound and so they may offer utility in the clinical setting particularly where surgical treatment is delayed."
10/01/2013 - "In this study, the effects of the wound-covering materials, Acticoat(®) and Cutinova Hydro(®) , on wound healing have been studied in rabbit models with open and tissue-lost wounds with full-thickness flank excisions. "
02/01/2006 - "In addition to the routine treatment, Acticoat was applied onto the wounds of the trial group once a day if there was much exudation from the wound, or the dressing change was made every other two days when the wounds were clean. "
05/01/2005 - "In a subsequent study, wounds were inoculated with strain SBI-N of Pseudomonas aeruginosa at 1 x 10(5) cfu/wound before the application of CSS or inoculated onto the surface of Acticoat. "

02/01/2011 - "This study confirmed our view that Acticoat is safe to use on patients with burns, even when they are extensive."
12/01/2007 - "This study has confirmed our view that Acticoat products are safe for use on burns and they remain a standard part of treatment at our centre."
01/01/2020 - "Histopathological Changes of Organs (Lungs, Liver, Kidney, and Brain) After Using Two Types of AgiCoat and Acticoat Nanosilver Dressings on Deep Second-Degree Burn in Rat."
12/31/2010 - "Retrospective comparison of two years in a paediatric burns unit, with and without acticoat as a standard dressing."
09/01/2010 - "Use of Acticoat dressings in burns: what is the evidence?"

03/01/2008 - "Two patients were successfully treated with Acticoat 7 dressings without using systemic antimicrobials after developing methicillin-resistant Staphylococcus aureus infection in the surgical site. "
01/01/2019 - "Acticoat reduced healing time, decreased the requirements for a general anaesthesia, reduced inpatient hospital stay and risk of infection."
01/01/2010 - "In patients at risk of surgical site infection (SSI), there is evidence that an antimicrobial barrier dressing (Acticoat* ) applied immediately post-procedure is effective in reducing the incidence of infection. "
05/01/1999 - "ACTICOAT dressing killed the bacteria that were tested much faster, which is a very important characteristic for a wound dressing acting as a barrier to invasive infection to have. "
10/01/2006 - "Acticoat 7 with Allevyn produced the lowest infection rate and thus became the dressing of choice for our BAHA programme."

01/01/2010 - "In patients at risk of surgical site infection (SSI), there is evidence that an antimicrobial barrier dressing (Acticoat* ) applied immediately post-procedure is effective in reducing the incidence of infection. "

08/01/2005 - "These audits demonstrate that Acticoat results in a reduced incidence of burn wound cellulitis, antibiotic use and overall cost compared to Silvazine in the treatment of early burn wounds."